168 related articles for article (PubMed ID: 37787041)
1. Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1.
Fang H; Ren W; Cui Q; Liang H; Yang C; Liu W; Wang X; Liu X; Shi Y; Feng J; Chen C
Elife; 2023 Oct; 12():. PubMed ID: 37787041
[TBL] [Abstract][Full Text] [Related]
2. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
3. Rac1-mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
Mori K; Higurashi M; Ishikawa F; Shibanuma M
Cancer Sci; 2021 Aug; 112(8):3205-3217. PubMed ID: 34036687
[TBL] [Abstract][Full Text] [Related]
4. Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
Evans R; Flores-Borja F; Nassiri S; Miranda E; Lawler K; Grigoriadis A; Monypenny J; Gillet C; Owen J; Gordon P; Male V; Cheung A; Noor F; Barber P; Marlow R; Francesch-Domenech E; Fruhwirth G; Squadrito M; Vojnovic B; Tutt A; Festy F; De Palma M; Ng T
Cell Rep; 2019 May; 27(7):1967-1978.e4. PubMed ID: 31091437
[TBL] [Abstract][Full Text] [Related]
5. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
Bierie B; Pierce SE; Kroeger C; Stover DG; Pattabiraman DR; Thiru P; Liu Donaher J; Reinhardt F; Chaffer CL; Keckesova Z; Weinberg RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2337-E2346. PubMed ID: 28270621
[TBL] [Abstract][Full Text] [Related]
6. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.
Kim BG; Gao MQ; Choi YP; Kang S; Park HR; Kang KS; Cho NH
Breast Cancer Res; 2012 Jun; 14(3):R88. PubMed ID: 22673183
[TBL] [Abstract][Full Text] [Related]
7. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
[TBL] [Abstract][Full Text] [Related]
8. KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.
Jia L; Zhou Z; Liang H; Wu J; Shi P; Li F; Wang Z; Wang C; Chen W; Zhang H; Wang Y; Liu R; Feng J; Chen C
Oncogene; 2016 Apr; 35(16):2040-51. PubMed ID: 26189798
[TBL] [Abstract][Full Text] [Related]
9. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
10. Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.
Wang K; Zou P; Zhu X; Zhang T
Toxicol In Vitro; 2019 Dec; 61():104653. PubMed ID: 31525383
[TBL] [Abstract][Full Text] [Related]
11. Rac1 is deactivated at integrin activation sites through an IQGAP1-filamin-A-RacGAP1 pathway.
Jacquemet G; Morgan MR; Byron A; Humphries JD; Choi CK; Chen CS; Caswell PT; Humphries MJ
J Cell Sci; 2013 Sep; 126(Pt 18):4121-35. PubMed ID: 23843620
[TBL] [Abstract][Full Text] [Related]
12. Rac1 repression reverses chemoresistance by targeting tumor metabolism.
Ganapathy-Kanniappan S
Cancer Biol Ther; 2020 Oct; 21(10):888-890. PubMed ID: 32866423
[TBL] [Abstract][Full Text] [Related]
13. SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α5 axis and inactivating Vav2/Rac1 signaling pathway.
Wang P; Liu GZ; Wang JF; Du YY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5481-5492. PubMed ID: 32495883
[TBL] [Abstract][Full Text] [Related]
14. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.
Xiong Z; Yang L; Li N; Fu J; Liu P; Sun P; Wei W; Xie X
Clin Transl Med; 2022 Dec; 12(12):e1133. PubMed ID: 36536485
[TBL] [Abstract][Full Text] [Related]
15. BPAG1e maintains keratinocyte polarity through beta4 integrin-mediated modulation of Rac1 and cofilin activities.
Hamill KJ; Hopkinson SB; DeBiase P; Jones JC
Mol Biol Cell; 2009 Jun; 20(12):2954-62. PubMed ID: 19403692
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
[TBL] [Abstract][Full Text] [Related]
17. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
Sung JS; Kang CW; Kang S; Jang Y; Chae YC; Kim BG; Cho NH
Oncogene; 2020 Jan; 39(3):664-676. PubMed ID: 31534187
[TBL] [Abstract][Full Text] [Related]
18. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
[TBL] [Abstract][Full Text] [Related]
19. beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1.
Pullar CE; Baier BS; Kariya Y; Russell AJ; Horst BA; Marinkovich MP; Isseroff RR
Mol Biol Cell; 2006 Nov; 17(11):4925-35. PubMed ID: 16914518
[TBL] [Abstract][Full Text] [Related]
20. Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line.
Lashgarian HE; Adamii V; Ghorbanzadeh V; Chodari L; Kamali F; Akbari S; Dariushnejad H
Drug Res (Stuttg); 2020 Oct; 70(10):478-483. PubMed ID: 32791535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
